StreetAlpha.app
Home › Stocks › OMCL

Omnicell, Inc. (OMCL)

Healthcare
$34.00
▼ −4.06%
LAST CLOSE · NOV 17

Omnicell makes medication dispensing automation, pharmacy robotics and analytics tools for hospitals and other pharmacies. It last closed at $34.00 on Nov 17, down 4.06% on the day. OMCL reports earnings on Thu, Feb 4, 2027.

AI Auto Pilots
Is OMCL in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$1.2B
+5.6% vs a year ago
Net income
$44.7M
+124.2% vs a year ago
EPS (diluted)
$0.96
+123.3% vs a year ago
Free cash flow
$145.8M
11.7% margin
Valuation
Market cap
$1.6B
46.0M shares
P/E
35.4
Price over 12 month EPS
Price to sales
1.3
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$314.9M
At Sep 30
Debt
$168.5M
At Sep 30
Shareholder equity
$1.3B
Shares outstanding
46.0M
At Oct 28
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $1.1B$1.1BFY2021FY2022: $1.3B$1.3BFY2022FY2023: $1.1B$1.1BFY2023FY2024: $1.1B$1.1BFY2024FY2025: $1.2B$1.2BFY2025

From OMCL's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 4). Last 12 months adds up the four latest quarters.

Next report
Feb 4
2027 · Time not announced
Consensus EPS forecast
$0.42
$298.6M revenue est.
Year-ago EPS
—
Not on file
Options-implied move
—
Posted about a week before
Analyst consensus
1 Buy
1 firm · not enough for a consensus
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Ratings · 90 days
1 Buy
1firm
1 Buy0 Hold0 Sell
Only 1 firm rated OMCL in the past 90 days, not enough for a consensus
Average 12-month target
$55.00
▲ 61.8% upside

Based on 1 analyst who set a price target on OMCL in the past 90 days. The average target is $55.00, with a high of $55.00 and a low of $55.00, compared with the last close of $34.00.

Low $55.00Avg $55.00High $55.00
Blue marker: last close $34.00
Highest target$55.00
Average target$55.00
Lowest target$55.00
Latest rating changes
Freedom Capital MarketsMaintained
Oct 31Buy$55
Piper SandlerReiterated
Aug 3Buy$45
Wells FargoMaintained
Jul 31Buy$50
KeybancMaintained
Jul 31Buy$65
DateFirmActionRatingPrice target
Oct 31Freedom Capital MarketsMaintainedBuy$55
Aug 3Piper SandlerReiteratedBuy$45
Jul 31Wells FargoMaintainedBuy$50
Jul 31KeybancMaintainedBuy$65
Loading…

Seasonality

How OMCL has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D

No whale options trades in OMCL in the last 90 days.

Loading…

See today’s whale options flow across the market →

OMCL Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bearish
Strongly bearishNeutralStrongly bullish
  • ●151 buying vs 143 selling
  • ▼Held by funds -2.1 pts
  • ▼Funds holding -5
  • ▼Superinvestors: 2 added, 3 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding303308−1.6%
In funds' top 1012−50.0%
Held by funds104.1%106.2%−2.1 pts
New / increased37 / 11453 / 116−10.7%
Reduced / sold out104 / 3986 / 21+33.6%
Put/call ratio0.003.68−100.0%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See OMCL institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether OMCL is in one of them and how their past OMCL trades turned out.

OMCL in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered OMCL in an article yet. Here's the latest on the wider market.

OMCL Congress Trades

All congress trades →
Trades, 12 months
1
Buys
0
0%
Sells
1
100%
People
1
Last filed Sep 22
Who traded OMCL · since 2015
Latest 3 filings
$15K – $50KTraded Jul 29, 2026Filed Sep 22, 2026
$50K – $100KTraded Apr 9, 2021Filed May 28, 2021
$1K – $15KTraded Feb 13, 2015Filed Feb 26, 2015
PersonTypeAmountTradedFiledDelay
Donald J TrumpExecutive branchSell$15K – $50KJul 29, 2026Sep 22, 202655 d
Sara JacobsD · CASell$50K – $100KApr 9, 2021May 28, 202149 d
Thom TillisR · NCSell$1K – $15KFeb 13, 2015Feb 26, 201513 d

Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.

About Omnicell

Omnicell is a healthcare technology company based in Fort Worth, Texas. It makes automated systems that store and dispense medications, robotics that handle pharmacy tasks, and data and analytics tools that support medication management. Its customers include hospitals and health systems, along with outpatient, retail, specialty, and long term care pharmacies. Some of its offerings are sold on subscription terms that include staff to run the equipment.

Headquarters
Fort Worth, TX